Dr. Michael Triplett is co-founder, President, and CEO of Armatus Bio, Inc., a gene therapy company based in Columbus, Ohio developing next generation precision therapies for genetically driven neuromuscular diseases, and Neucore Bio, Inc., a gene therapy company developing next generation nonviral precision therapeutics for genetically driven neurological diseases. Dr. Triplett is co-founder and board co-Chair of Clarametyx Biosciences, Inc., a clinical stage infectious disease company pursuing paradigm shifting therapeutics and vaccines for the treatment and prevention of bacterial biofilm mediated diseases, after serving as founding President and CEO. Dr. Triplett co-founded and served as President and CEO of Myonexus Therapeutics, a stage gene therapy company developing first-ever treatments for limb-girdle muscular dystrophies acquired by Sarepta Therapeutics.
Dr. Triplett began his career at Procter & Gamble as a Product Development Engineer prior to attending graduate school. After completing his graduate research in lipid nanoparticle engineering, he joined Battelle where he held roles of progressing responsibility, spanning business development, innovation, new venture development, and corporate strategy.
Dr. Triplett serves on several boards, including Andelyn Biosciences, NeuroTech Institute, the InnovateOhio Advisory Board, the Ohio Federal Research Network Executive Review Board, the Ohio Life Sciences Association where he is Chair, and the Ohio Gene and Cell Therapy Council. He also serves as a Venture Advisor to the Ohio Innovation Fund, a Columbus, Ohio based venture capital fund. Dr. Triplett is a Founding Partner of Carmen Ventures, an emerging venture capital fund created by Ohio State University alumni with the mission of investing in Ohio State University alumni led and IP based ventures.
Excelling at the interfaces of business and biotech innovation, Dr. Triplett is passionate about translating world-class science and technology into transformative businesses, products, and capabilities that enhance human health, American competitiveness, and economic opportunity. Dr. Triplett focuses on life sciences technology ventures, innovation, technology-based economic development, and science, technology, engineering, and math (STEM) education.
A first-generation college graduate, Dr. Triplett received his B.S. in Chemical Engineering (summa cum laude) and Ph.D. in Chemical Engineering from Ohio State University as a United States Department of Defense National Defense Science and Engineering Graduate Fellow and University Fellow.
A native of East Liverpool, Ohio, Dr. Triplett currently resides in New Albany, Ohio, with his wife and daughters.